One-Year Results of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy

INTRODUCTION: To evaluate 1-year outcomes of intravitreal aflibercept (IVA) using a treat-and-extend (TAE) regimen for polypoidal choroidal vasculopathy (PCV) and identify the factors for patients whose treatment intervals could be extended. METHODS: Fifty-one eyes of treatment-naïve PCV patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamachi, Tomoko, Kohno, Takeya, Yamamoto, Manabu, Hirayama, Kumiko, Kyo, Akika, Ueda, Nobuhiko, Hirabayashi, Michiko, Shiraki, Kunihiko, Honda, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708582/
https://www.ncbi.nlm.nih.gov/pubmed/33058069
http://dx.doi.org/10.1007/s40123-020-00312-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708582/
https://www.ncbi.nlm.nih.gov/pubmed/33058069
http://dx.doi.org/10.1007/s40123-020-00312-3

Ejemplares similares